Johnson & Johnson
Develops prescription medicines and cardiovascular, surgical, orthopaedic and vision technologies.
$268.40
After-hours close+0.36 (+0.13%)
At close$268.04(+0.85%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 114.40%Insiders 0.04%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 2.41B · Float 2.41B · 99.8% free float
Institutions13F, as of Jun 30, 2026
4,785 holders · 2.76B shares · 230 new positions · 2,270 increased · 1,915 reduced · 193 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 212.10M | 8.80% | −1.29M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 157.23M | 6.52% | +621.0K | Aug 13, 2026 |
| State Street Corp | 133.78M | 5.55% | +299.7K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 64.37M | 2.67% | +856.4K | Aug 13, 2026 |
| Geode Capital Management, LLC | 59.09M | 2.45% | −78.4K | Aug 12, 2026 |
| JPMorgan Chase & Co | 58.30M | 2.42% | −4.79M | Aug 12, 2026 |
| Morgan Stanley | 44.81M | 1.86% | +87.1K | Aug 13, 2026 |
| Norges Bank | 31.83M | 1.32% | +31.83Mnew | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.49% | 180.63M | 13G | May 1, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Joaquin Duato | director, officer: CEO and Chairman of the Board | 306.8K | 0.01% | Aug 14, 2026 |
| Jennifer L. Taubert | officer: EVP, WWC. Innovative Medicine | 194.5K | 0.01% | Aug 18, 2026 |
| Kathryn E. Wengel | officer: EVP, Chief TO and Risk Officer | 114.3K | 0.00% | Jun 12, 2026 |
| Joseph J. Wolk | officer: Exec VP, CFO | 82.8K | 0.00% | Feb 18, 2026 |
| James D. Swanson | officer: EVP, CIO | 25.7K | 0.00% | Feb 18, 2026 |
| Timothy Schmid | officer: EVP, WW Chair, MedTech | 25.4K | 0.00% | Feb 23, 2026 |
| John C. Reed | officer: EVP, Innovative Medicine, R&D | 24.9K | 0.00% | May 4, 2026 |
| Robert J. Decker | officer: VP Corporate Controller | 23.7K | 0.00% | Mar 3, 2026 |
| Vanessa Broadhurst | officer: EVP, Global Corp Affairs | 23.0K | 0.00% | Jul 21, 2026 |
| Kristen Mulholland | officer: EVP, Chief HR Officer | 19.5K | 0.00% | Feb 18, 2026 |
38 people have not refiled in the last 18 months (2.72M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Jennifer L. Taubertofficer: EVP, WWC. Innovative Medicine | Sale | 15,000 | $263.36 | 194,451 |
| Aug 13, 2026 | Joaquin Duatodirector, officer: CEO and Chairman of the Board | Sale · 2 lots | 123,291 | $261.17 | 275,967 |
| Aug 6, 2026 | Elizabeth Forminardofficer: EVP, Chief Legal Officer | Sale · 2 lots | 15,918 | $257.00 | 16,994 |
| Aug 5, 2026 | Joaquin Duatodirector, officer: CEO and Chairman of the Board | Sale · 2 lots | 48,480 | $258.15 | 275,967 |
| Jul 20, 2026 | Vanessa Broadhurstofficer: EVP, Global Corp Affairs | Sale | 23,054 | $251.27 | 23,003 |
| Jun 11, 2026 | Kathryn E. Wengelofficer: EVP, Chief TO and Risk Officer | Sale | 10,000 | $241.15 | 114,288 |
| Feb 27, 2026 | Robert J. Deckerofficer: VP Corporate Controller | Sale | 4,075 | $247.87 | 23,682 |
| Feb 20, 2026 | Timothy Schmidofficer: EVP, WW Chair, MedTech | Sale | 1,322 | $245.66 | 25,447 |
| Feb 17, 2026 | Vanessa Broadhurstofficer: EVP, Global Corp Affairs | Sale | 6,197 | $243.39 | 23,003 |
| Feb 18, 2026 | Timothy Schmidofficer: EVP, WW Chair, MedTech | Sale · 2 lots | 22,623 | $244.33 | 26,769 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Rich McCormick | Sale | $1,001 – $15,000 | Jul 30, 2026 | Aug 17, 2026 ↗ | |
| Rep. Ro Khanna · CA17 | Purchase | $1,001 – $15,000 | Jul 2, 2026 | Aug 12, 2026 ↗ | |
| Sen. Tommy Tuberville · AL | Sale | $15,001 – $50,000 | Joint | Oct 29, 2024 | Aug 5, 2026 ↗ |
| Rep. Thomas H. Kean · NJ07 | Sale | $1,001 – $15,000 | Jun 29, 2026 | Jul 16, 2026 ↗ | |
| Rep. Thomas H. Kean · NJ07 | Sale | $1,001 – $15,000 | Jun 2, 2026 | Jul 16, 2026 ↗ |